Vir Biotechnology (VIR) EBT Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.28 Mn |
| Dec 31, 2025 | 6.78 Mn |
| Sep 30, 2025 | -5.88 Mn |
| Jun 30, 2025 | -513,678.00 |
| Mar 31, 2025 | -314,316.00 |
| Dec 31, 2024 | 812,634.00 |
| Sep 30, 2024 | -442,300.00 |
| Jun 30, 2024 | -442,354.00 |
| Mar 31, 2024 | 59,362.00 |
| Dec 31, 2023 | 559,463.00 |
| Sep 30, 2023 | -110,927.00 |
| Jun 30, 2023 | -497,728.00 |
| Mar 31, 2023 | 7,946.00 |
| Dec 31, 2022 | -36,503.00 |
| Sep 30, 2022 | 63,339.00 |
| Jun 30, 2022 | -65,006.00 |
| Mar 31, 2022 | 764.00 |
| Dec 31, 2021 | -3,973.00 |
| Sep 30, 2021 | 7,014.00 |
| Jun 30, 2021 | 857,497.00 |
| Mar 31, 2021 | -180,436.00 |
| Dec 31, 2020 | -234,656.00 |
| Sep 30, 2020 | -431,542.00 |
| Jun 30, 2020 | 127,867.00 |
| Mar 31, 2020 | 514,150.00 |
| Dec 31, 2019 | -304,749.00 |
| Sep 30, 2019 | -178,803.00 |
| Jun 30, 2019 | -87,340.00 |
| Mar 31, 2019 | 6,055.00 |
| Dec 31, 2018 | 31,599.00 |